Tovanor Breezhaler
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tovanor Breezhaler, covering 2026-01-26 to 2026-01-26. Get the full timeline:
Most recent: EMA Authorised: Tovanor Breezhaler (glycopyrronium bromide) — Novartis Europharm Limited